RUA Life Sciences plc (AIM:RUA)
London · Delayed Price · Currency is GBP · Price in GBX 17.87
-0.13 (-0.72%)
Apr 17, 2026, 3:01 PM GMT
RUA Life Sciences Market Cap
RUA Life Sciences has a market cap or net worth of 11.17 million as of April 17, 2026. Its market cap has increased by 53.19% in one year.
Market Cap
11.17M
Enterprise Value
8.76M
Revenue
4.46M
Ranking
n/a
PE Ratio
n/a
Stock Price
17.87
Market Cap Chart
Since February 26, 1997, RUA Life Sciences's market cap has decreased from 23.82M to 11.17M, a decrease of -53.11%. That is a compound annual growth rate of -2.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 16, 2026 | 11.17M | 28.57% |
| Dec 31, 2025 | 8.69M | 27.27% |
| Dec 31, 2024 | 6.83M | 11.68% |
| Dec 29, 2023 | 6.11M | -43.19% |
| Dec 30, 2022 | 10.76M | -35.33% |
| Dec 31, 2021 | 16.64M | -50.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 230.51B |
| GSK plc | 84.81B |
| Haleon | 31.43B |
| Smith & Nephew | 10.83B |
| genedrive | 15.25M |
| Genflow Biosciences | 12.05M |
| CelLBxHealth | 10.23M |
| Oxford BioDynamics | 9.23M |